BioNTech to Host Second AI Day (investors.biontech.de)

BioNTech and its AI arm InstaDeep will hold a second “AI Day” on October 1, 2025 in London to present the company’s AI strategy, capabilities and how AI is being applied across its drug pipeline and internal processes. The event—part of BioNTech’s Innovation Series—will be webcast live and slides/recordings will be posted on the company’s Investor Relations site and archived for one year. For the AI/ML community this is a high-profile example of an industrial biotech deepening and publicizing its AI investments. BioNTech frames AI as integral to its computational discovery and therapeutic modalities (mRNA vaccines, immunomodulators, ADCs, CAR‑T), so attendees can reasonably expect discussion of model-driven candidate prioritization, in silico screening, biomarker and patient‑stratification tools, and manufacturing or process‑optimization pipelines. The involvement of InstaDeep signals a move toward production‑grade ML deployments and partner-driven innovation. The press release does not include technical specifics (architectures, datasets or performance metrics), but the session should provide useful insight into practical ML workflows, translational use cases, and potential collaboration opportunities between AI researchers and drug developers.